Carregant...
Sweet’s syndrome after adalimumab therapy for refractory relapsing polychondritis
Relapsing polychondritis and Sweet’s syndrome are rare systemic inflammatory conditions. The authors present a patient who developed Sweet’s syndrome 1 week after adalimumab therapy for refractory relapsing polychondritis. Coexistent relapsing polychondritis and Sweet’s syndrome is rare, however, is...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3246157/ https://ncbi.nlm.nih.gov/pubmed/22670004 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr.10.2011.4935 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|